Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations

Neoplasia

Volumn 11, Issue 2, 2009, Pages 102-125

  Padhani, Anwar R ^a   Liu, Guoying ^b   Mu Koh, Dow ^c   Chenevert, Thomas L ^d   Thoeny, Harriet C ^e   Takahara, Taro ^f   Dzik Jurasz, Andrew ^g   Ross, Brian D ^d   Van Cauteren, Marc ^h   Collins, David ^c   Hammoud, Dima A ⁱ   Rustin, Gordon J S ^a   Taouli, Bachir ^j   Choyke, Peter L ^b  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d Center for Molecular Imaging   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g NOVARTIS PHARMA AG   (Switzerland)

^h MR Asia Pacific   (Japan)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMBRESTATIN A4 PHOSPHATE; IMATINIB; TRASTUZUMAB; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

BRAIN TUMOR; BREAST CANCER; BREAST TUMOR; CANCER RESEARCH; CANCER STAGING; CLINICAL ASSESSMENT; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; GASTROINTESTINAL STROMAL TUMOR; HEAD AND NECK CANCER; HEALTH CARE PERSONNEL; HUMAN; IMAGE ANALYSIS; PRIORITY JOURNAL; RECTUM CANCER; SQUAMOUS CELL CARCINOMA; TISSUE CHARACTERIZATION; TREATMENT RESPONSE;

EID: 61349123591     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.81328     Document Type: Conference Paper

References (84)

1. Rudin M (2007). Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions. Eur Radiol 17 (10), 2441-2457.
2. Johnston KC,Wagner DP,Wang XQ,Newman GC, Thijs V, Sen S, andWarach S (2007). Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome?. Stroke 38 (6), 1820-1825.
3. Chenevert TL, Brunberg JA, and Pipe JG (1990). Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177 (2), 401-405.
4. Stejskal EO and Tanner JE (1965). Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys 42, 288-292.
5. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, and Laval-Jeantet M (1988). Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168, 497-505.
6. Le Bihan D, Delannoy DJ, and Levin RL (1988). Temperature mapping with MR imaging of molecular diffusion: application to hyperthermia. Radiology 171, 853-857.
7. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, Tsuruda J, and Norman D (1990). Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 176 (2), 439-445.
8. Lee JH and Springer CS Jr (2003). Effects of equilibrium exchange on diffusionweighted NMR signals: the diffusigraphic "shutter-speed". Magn Reson Med 49 (3), 450-458.
9. Norris DG (2001). The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed 14 (2), 77-93.
10. Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, andNicolay K (1996). Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med 36 (6), 847-857.
11. Mulkern RV,Gudbjartsson H,Westin CF, ZengingonulHP, GartnerW,Guttmann CR, Robertson RL, Kyriakos W, Schwartz R, Holtzman D, et al. (1999). Multicomponent apparent diffusion coefficients in human brain. NMR Biomed 12 (1), 51-62.
12. Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, and Hyde JS (2003). Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med 50, 727-734.
13. Thoeny HC and De Keyzer F (2007). Extracranial applications of diffusionweighted magnetic resonance imaging. Eur Radiol 17 (6), 1385-1393.
14. Patterson DM, Padhani AR, and Collins DJ (2008). Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 5 (4), 220-233.
15. Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, Kitajima M, Hirai T, Yamashita Y, and Mizuta H (2006). Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16, 2637-2643.
16. Guo Y, Gao YG, An NY, Ma L, Mahankali S, and Gao JH (2002). Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16, 172-178.
17. Humphries PD, Sebire NJ, Siegel MJ, and Olsen OE (2007). Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 245 (3), 848-854.
18. Squillaci E, Manenti G, Cova M, Di Roma M, Miano R, Palmieri G, and Simonetti G (2004). Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 24 (6), 4175-4179.
19. Manenti G, Di Roma M, Mancino S, Bartolucci DA, Palmieri G, Mastrangeli R, Miano R, Squillaci E, and Simonetti G (2008). Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T. Radiol Med 113 (2), 199-213.
20. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, et al. (1999). Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9, 53-60.
21. Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H, and Imai Y (2008). Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 26 (4), 222-226.
22. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, and Menu Y (2003). Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echoplanar MR imaging sequences: prospective study in 66 patients. Radiology 226, 71-78.
23. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, and Taouli B (2008). Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246 (3), 812-822.
24. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, and Bassett LW (2002). In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 15, 693-704.
25. Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, Watanabe M, and Hayakawa K (2005). Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29, 644-649.
26. Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H, and Nakamura T (2003). Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 24, 1627-1634.
27. King AD, Ahuja AT, Yeung DKW, Fong DK, Lee YY, Lei KI, and Tse GM (2007). Malignant cervical lymphadenopathy: diagnostic accuracy of diffusionweighted MR imaging. Radiology 245, 806-813.
28. Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, et al. (2005). Effect of vascular targeting agent in rat tumor model: dynamic contrastenhanced versus diffusion-weighted MR imaging. Radiology 237, 492-499.
29. Hamstra D, Rehemtulla A, and Ross BD (2007). Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J ClinOncol 25, 4104-4109.
30. Thoeny HC, De Keyzer F, Chen F, Ni Y, Landuyt W, Verbeken EK, Bosmans H, Marchal G, and Hermans R (2005). Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234, 756-764.
31. Pickles MD, Gibbs P, Lowry M, and Turnbull LW (2006). Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24, 843-847.
32. Yankeelov TE, Lepage M, Chakravarthy A, Broome E, Niermann K, Kelley M, Meszoely I, Mayer I, Herman C, and McManus K (2007). Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25, 1-13.
33. Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, and Stopeck A (2004). Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6, 831-837.
34. Kamel IR, Reyes DK, Liapi E, Bluemke DA, and Geschwind JF (2007). Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Intervent Radiol 18, 49-56.
35. Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, KÖhler G, Ilyasov K, and Langer M (2006). Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusionweighted magnetic resonance imaging. Invest Radiol 41, 618-623.
36. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A, Baram J, Orenstein A, et al. (2003). Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21 (6), 1094-1100.
37. Eichler AF, Batchelor TT, and Henson JW (2007). Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Neuro Oncol 9 (3), 373-377.
38. Zbaren P,Weidner S, and Thoeny HC (2008). Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma. Curr Opin Otolaryngol Head Neck Surg 16 (2), 147-153.
39. Thoeny HC, De Keyzer F, Chen F, Vandecaveye V, Verbeken EK, Ahmed B, Sun X, Ni Y, Bosmans H, Hermans R, et al. (2005). Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7, 779-787.
40. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, and Doran S (2002). Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360 (9329), 307-308.
41. DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, Pfeiffer KP, Lukas P, and Judmaier W (2003). Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56 (4), 958-965.
42. Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, and Ross BD, (2000). Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 (24), 2029-2036.
43. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, and Gillies RJ, (1999). Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1 (2), 113-117.
44. Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR, and Chang CY (2008). Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 190 (2), 481-488.
45. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, and Van Cauteren M (2004). Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22 (4), 275-282.
46. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, and Luijten PR (2008). Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18 (9), 1937-1952.
47. Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R, Rordorf G, Buonanno FS, Schaefer PW, and Gonzalez RG (1998). Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 29 (11), 2268-2276.
48. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, et al. (2008). Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63 (1), 52-60.
49. Reddy JS, Mishra AM, Behari S, Husain M, Gupta V, Rastogi M, and Gupta RK (2006). The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol 66 (3), 246-250; discussion 250-251.
50. Schroeder PC, Post MJ, Oschatz E, Stadler A, Bruce-Gregorios J, and Thurnher MM (2006). Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 48 (10), 715-720.
51. Engelhorn T, Hufnagel A,Weise J, Baehr M, and Doerfler A (2007).Monitoring of acute generalized status epilepticus using multilocal diffusion MR imaging: early prediction of regional neuronal damage. AJNR Am J Neuroradiol 28 (2), 321-327.
52. Dechambre S, Duprez T, Lecouvet F, Raftopoulos C, and Gosnard G (1999). Diffusion-weighted MRI postoperative assessment of an epidermoid tumour in the cerebellopontine angle. Neuroradiology 41 (11), 829-831.
53. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, and Yamada R (2001). The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22 (6), 1081-1088.
54. Sijens PE, Heesters MA, Enting RH, van der Graaf WT, Potze JH, Irwan R, Meiners LC, and Oudkerk M (2007). Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomidechemotherapy. Cancer Invest 25 (8), 706-710.
55. Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK, Quint DJ, Gebarski SS, Fan X, Tsien CI, et al. (2005). Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 102 (46), 16759-16764.
56. Mori S and van Zijl PC (2002). Fiber tracking: principles and strategies-a technical review. NMR Biomed 15 (7-8), 468-480.
57. Goebell E, Paustenbach S, Vaeterlein O, Ding XQ, Heese O, Fiehler J, Kucinski T, Hagel C, Westphal M, and Zeumer H (2006). Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 239 (1), 217-222.
58. Stadlbauer A, Ganslandt O, Buslei R, Hammen T,Gruber S,Moser E, Buchfelder M, Salomonowitz E, and Nimsky C (2006). Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 240 (3), 803-810.
59. Rustin GJ, Nelstrop AE, Bentzen SM, Bond SJ, and McClean P (2000). Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials. J Clin Oncol 18 (8), 1733-1739.
60. Bammer R (2003). Basic principles of diffusion-weighted imaging. Eur J Radiol 45 (3), 169-184.
61. Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, Chau I, Cunningham D, deSouza NM, Leach MO, et al. (2008). Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 18 (5), 903-910.
62. Nasu K, Kuroki Y, Sekiguchi R, and Nawano S (2006). The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 5 (3), 129-136.
63. Koh DM, Scurr E, Collins DJ, Pirgon A, Kanber B, Karanjia N, Brown G, Leach MO, and Husband JE (2006). Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol 16 (9), 1898-1905.
64. Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, Fujii M, and Sugimura K (2006). ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 187 (6), 1521-1530.
65. Yamada I, Aung W, Himeno Y, Nakagawa T, and Shibuya H (1999). Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210, 617-623.
66. Ichikawa T, Haradome H, Hachiya J, Nitatori T, and Araki T (1998). Diffusionweighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170 (2), 397-402.
67. Ichikawa T, Haradome H, Hachiya J, Nitatori T, and Araki T (1999). Diffusionweighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 24 (5), 456-461.
68. Ichikawa T, Erturk SM,Motosugi U, Sou H, Iino H, Araki T, and FujiiH(2006). High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 187 (1), 181-184.
69. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, and Takizawa O (2005). Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15 (1), 71-78.
70. Westin CF, Maier SE, Mamata H, Nabavi A, Jolesz FA, and Kikinis R (2002). Processing and visualization for diffusion tensor MRI. Med Image Anal 6 (2), 93-108.
71. Tozer DJ, Davies GR, Altmann DR, Miller DH, and Tofts PS (2006). Principal component and linear discriminant analysis of T1 histograms of white and grey matter in multiple sclerosis. Magn Reson Imaging 24 (6), 793-800.
72. Moffat BA, Chenevert TL, and Lawrence TS (2005). Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102, 5524-5529.
73. Lee S, Choi M, Kim H, and Park FC (2007). Geometric direct search algorithms for image registration. IEEE Trans Image Process 16 (9), 2215-2224.
74. Tofts PS, Lloyd D, Clark CA, Barker GJ, Parker GJ, McConville P, Baldock C, and Pope JM (2000). Test liquids for quantitative MRI measurements of selfdiffusion coefficient in vivo. Magn Reson Med 43 (3), 368-374.
75. Delakis I, Moore EM, Leach MO, and De Wilde JP (2004). Developing a quality control protocol for diffusion imaging on a clinical MRI system. Phys Med Biol 49 (8), 1409-1422.
76. Laubach HJ, Jakob PM, Loevblad KO, Baird AE, Bovo MP, Edelman RR, and Warach S (1998). A phantom for diffusion-weighted imaging of acute stroke. J Magn Reson Imaging 8 (6), 1349-1354.
77. Price WS, Barzykin AV, Hayamizu K, and Tachiya M (1998). A model for diffusive transport through a spherical interface probed by pulsed-field gradient NMR. Biophys J 74 (5), 2259-2271.
78. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996). Diffusion tensor MR imaging of the human brain. Radiology 201 (3), 637-648.
79. Sener RN (2001). Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values. Comput Med Imaging Graph 25 (4), 299-326.
80. Simmons A, Moore E, and Williams SC (1999). Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magn Reson Med 41 (6), 1274-1278.
81. Horsfield MA (1999). Mapping eddy current induced fields for the correction of diffusion-weighted echo planar images. Magn Reson Imaging 17 (9), 1335-1345.
82. Jezzard P, Barnett AS, and Pierpaoli C (1998). Characterization of and correction for eddy current artifacts in echo planar diffusion imaging. Magn Reson Med 39 (5), 801-812.
83. Mattila S, Renvall V, Hiltunen J, Kirven D, Sepponen R, Hari R, and Tarkiainen A (2007). Phantom-based evaluation of geometric distortions in functional magnetic resonance and diffusion tensor imaging. Magn Reson Med 57 (4), 754-763.
84. Reese TG, Heid O, Weisskoff RM, and Wedeen VJ (2003). Reduction of eddycurrent- induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med 49 (1), 177-182.